[go: up one dir, main page]

ES8702139A1 - Un procedimiento para preparar un nuevo compuesto heteroci- clico condensado con benceno - Google Patents

Un procedimiento para preparar un nuevo compuesto heteroci- clico condensado con benceno

Info

Publication number
ES8702139A1
ES8702139A1 ES548205A ES548205A ES8702139A1 ES 8702139 A1 ES8702139 A1 ES 8702139A1 ES 548205 A ES548205 A ES 548205A ES 548205 A ES548205 A ES 548205A ES 8702139 A1 ES8702139 A1 ES 8702139A1
Authority
ES
Spain
Prior art keywords
hydrogen
image
formula
compound
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES548205A
Other languages
English (en)
Other versions
ES548205A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848427124A external-priority patent/GB8427124D0/en
Priority claimed from GB858513399A external-priority patent/GB8513399D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES8702139A1 publication Critical patent/ES8702139A1/es
Publication of ES548205A0 publication Critical patent/ES548205A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR UN NUEVO COMPUESTO HETEROCICLICO CONDENSADO CON BENCENO. CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA R4NHNH2, A TEMPERATURA COMPRENDIDA ENTRE EL ENFRIAMIENTO HASTA EL CALENTAMIENTO, PARA OBTENER COMPUESTOS HETEROCICLICOS CONDENSADOS CON BENCENO DE FORMULA (I), DONDE R1 ES HALOGENO, NITRO, HIDROXI, ALQUILO INFERIOR, ALCOXI INFERIOR SUSTITUIDO POR CARBOXI O CARBOXI PROTEGIDO, ACILAMINO QUE PUEDE TENER UN ALQUILO INFERIOR EN EL RESTO DE AMINO, O ARILOXI QUE PUEDE TENER HALOGENO; R2 ES HIDROGENO O HALOGENO; X ES O U OTROS; Y A ES UN GRUPO DE FORMULA (III) DONDE R4 ES H, ALQUENILO INFERIOR, ALQUENILO INFERIOR O ALQUILO QUE PUEDE TENER UNO O VARIOS SUSTITUYENTES U OTROS. TIENE UTILIDADES FARMACOLOGICAS POR SU ACTIVIDAD DIURETICA, URICOSURICA Y VASODILATADORA.
ES548205A 1984-10-26 1985-10-25 Un procedimiento para preparar un nuevo compuesto heteroci- clico condensado con benceno Expired ES8702139A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848427124A GB8427124D0 (en) 1984-10-26 1984-10-26 Benzene-fused heterocyclic compound
GB858513399A GB8513399D0 (en) 1985-05-28 1985-05-28 Heterocyclic compound

Publications (2)

Publication Number Publication Date
ES8702139A1 true ES8702139A1 (es) 1986-12-16
ES548205A0 ES548205A0 (es) 1986-12-16

Family

ID=26288380

Family Applications (2)

Application Number Title Priority Date Filing Date
ES548205A Expired ES8702139A1 (es) 1984-10-26 1985-10-25 Un procedimiento para preparar un nuevo compuesto heteroci- clico condensado con benceno
ES557041A Expired ES8801266A1 (es) 1984-10-26 1986-09-01 Un procedimiento para preparar nuevos compuestos heterociclicos condensados con benceno

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557041A Expired ES8801266A1 (es) 1984-10-26 1986-09-01 Un procedimiento para preparar nuevos compuestos heterociclicos condensados con benceno

Country Status (16)

Country Link
US (2) US4675324A (es)
EP (1) EP0180352B1 (es)
JP (1) JPH0649702B2 (es)
KR (1) KR860003259A (es)
CN (1) CN85108618A (es)
AT (1) ATE89825T1 (es)
AU (1) AU4855185A (es)
DE (1) DE3587362T2 (es)
DK (1) DK493185A (es)
ES (2) ES8702139A1 (es)
FI (1) FI853757L (es)
GR (1) GR852593B (es)
HU (1) HUT40124A (es)
NO (1) NO854275L (es)
PH (1) PH21213A (es)
SU (1) SU1375137A3 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839368A (en) * 1986-05-02 1989-06-13 Mochida Pharmaceutical Co., Ltd. 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives
US4816467A (en) * 1987-01-09 1989-03-28 Farmitalia Carlo Erba S.R.L Heteroaryl 3-oxo-propanenitrile derivatives, pharmaceutical compositions and use
JPH02502906A (ja) * 1987-04-09 1990-09-13 イー・アイ・デユポン・デ・ニモアス・アンド・カンパニー 殺虫性置換インダゾール類
JP2602037B2 (ja) * 1987-10-31 1997-04-23 持田製薬株式会社 １−アシル−２，３−ジヒドロ−４（１ｈ）−キノリノン−４−オキシム誘導体、その製法およびそれらを主成分とする利尿、降圧、抗浮腫および腹水除去用医薬組成物
US5192768A (en) * 1990-09-14 1993-03-09 Kyowa Hakko Kogyo Co., Ltd. Pyrazoloquinoline derivatives
ATE239710T1 (de) 1994-06-15 2003-05-15 Otsuka Pharma Co Ltd Benzoheterocyclische derivate verwendbar als vasopressin- oder oxytocin-modulatoren
US5865170A (en) * 1997-07-23 1999-02-02 Moles; Randall C. Customizable mouthpiece for scuba-divers
DE60311861T2 (de) * 2002-11-22 2007-11-22 Active Biotech Ab Pyrazolochinoline mit immunmodulierender wirkung
EP1667643A4 (en) * 2003-08-28 2008-03-05 Nitromed Inc NITROSIS AND NITROSYL CARDIOVASCULAR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
CA2597460A1 (en) * 2005-02-24 2006-08-31 Nitromed, Inc. Nitric oxide enhancing diuretic compounds, compositions and methods of use
ES2381879T3 (es) 2006-12-29 2012-06-01 Abbott Gmbh & Co. Kg Compuestos de carboxamida y su uso como inhibidores de calpaína

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2009079A1 (es) * 1968-05-22 1970-01-30 Sandoz Sa
US3624102A (en) * 1969-05-21 1971-11-30 Warner Lambert Co Substituted benzopyranopyrazoles
DE3068673D1 (en) * 1979-06-21 1984-08-30 Ciba Geigy Ag Pyrazolo-quinolines, processes for their production, and pharmaceutical compositions containing them
US4524146A (en) * 1982-12-08 1985-06-18 Ciba-Geigy Corporation Certain -2-heterocycle substituted pyrazoloquinolines

Also Published As

Publication number Publication date
JPH0649702B2 (ja) 1994-06-29
DK493185A (da) 1986-04-27
ES8801266A1 (es) 1987-12-16
ATE89825T1 (de) 1993-06-15
PH21213A (en) 1987-08-21
NO854275L (no) 1986-04-28
FI853757A0 (fi) 1985-09-30
JPS61112076A (ja) 1986-05-30
GR852593B (es) 1985-12-24
DE3587362T2 (de) 1993-09-09
ES548205A0 (es) 1986-12-16
FI853757L (fi) 1986-04-27
ES557041A0 (es) 1987-12-16
DK493185D0 (da) 1985-10-25
US4767780A (en) 1988-08-30
AU4855185A (en) 1986-05-01
EP0180352B1 (en) 1993-05-26
EP0180352A2 (en) 1986-05-07
KR860003259A (ko) 1986-05-21
SU1375137A3 (ru) 1988-02-15
CN85108618A (zh) 1986-08-27
DE3587362D1 (de) 1993-07-01
US4675324A (en) 1987-06-23
EP0180352A3 (en) 1988-03-30
HUT40124A (en) 1986-11-28

Similar Documents

Publication Publication Date Title
ES8801245A1 (es) Un procedimiento para preparar derivados de piperidina
IL62111A (en) Phenylalkenyl imidazole derivatives,their preparation and pharmaceutical compositions containing them
ES8702139A1 (es) Un procedimiento para preparar un nuevo compuesto heteroci- clico condensado con benceno
ES2006623A6 (es) Procedimiento de preparacion de nuevos derivados de amino 5,6,7,8-tetrahidro-(2,3b)-nafto-furano.
ES8800270A1 (es) Un procedimiento para preparar derivados de aminoacidos
MY101801A (en) Novel phenoxyacetic acid derivatives, process for preparing the same and pharmaceutical composition having the same as an active ingredient.
IL64647A (en) 2,8-disubstituted-4-thiomorpholino-pyrimido(5,4-d)pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
ES8301219A1 (es) Procedimiento para la preparacion de 2-fenilamino-imidazoli-nas-(2) sustituidas
ES8703861A1 (es) Un procedimiento para preparar nuevas 1,2,4-tiadiazinas
ES8800230A1 (es) Un procedimiento para preparar compuestos heterociclicos fusionados con benceno